Athol Wells

25PUBLICATIONS
111CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Clinical chemistry (incl. diagnostics)Cell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jan 08, 2026
Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary Fibrosis.

John A Mackintosh, Simon L F Walsh, Mario Silva

|Feb 04, 2025
CT Prognostication across the Whole Spectrum of Fibrotic Interstitial Lung Disease: Implications and Opportunities.

Athol U Wells

|Jan 03, 2025
Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis.

Nina R Goldman, Svetlana I Nihtyanova, Claire F Beesley

|Mar 27, 2024
Optimal clinical practice in IPF and PPF: Integrating the scientific ethos and clinical reasoning.

Athol U Wells

|Mar 13, 2024
The impact of hiatus hernia in hypersensitivity pneumonitis.

David A Heriot, Carmel J W Stock, Zain-Ul-Abideen Mumtaz

|Feb 14, 2024
Low bleeding rates following transbronchial lung cryobiopsy in unclassifiable interstitial lung disease.

John Taverner, Carmen M Lucena, Justin L Garner

Pageof 5

Frequent Collaborators

7 joint publications

Elizabetta A Renzoni

4 joint publications

Carmel J W Stock

4 joint publications

Felix Chua

3 joint publications

Peter M George